Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Raihan Rabbani

3PUBLICATIONS
4CO-AUTHORS
Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Mar 03, 2022
Therapeutic safety and efficacy of triple-immunosuppressants versus dual-immunosuppressants in severe-to-critical COVID-19: a prospective cohort study in Bangladesh.

Md Jahidul Hasan, Raihan Rabbani, Ahmad Mursel Anam

|May 08, 2021
Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh.

Md Jahidul Hasan, Raihan Rabbani, Ahmad Mursel Anam

|Dec 28, 2020
Additional baricitinib loading dose improves clinical outcome in COVID-19.

Md Jahidul Hasan, Raihan Rabbani, Ahmad Mursel Anam

Pageof 1

Frequent Collaborators

3 joint publications

Md Jahidul Hasan

3 joint publications

Ahmad Mursel Anam

2 joint publications

Shihan Mahmud Redwanul Huq

1 joint publications

Sitesh C Bachar

Frequent Collaborators

3 joint publications

Md Jahidul Hasan

3 joint publications

Ahmad Mursel Anam

2 joint publications

Shihan Mahmud Redwanul Huq

1 joint publications

Sitesh C Bachar

Top Related Videos

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on : Jun 15, 2019

10.2K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

Published on : Apr 05, 2017

8.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.3K
See more related videos

Top Related Videos

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on : Jun 15, 2019

10.2K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

Published on : Apr 05, 2017

8.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.3K
See more related videos